K
Kymera Therapeutics
Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020
Kymera Therapeutics mafia
Startups founded by Kymera Therapeutics alumni
Former Kymera Therapeutics employees who went on to start their own companies. Sorted by Dealroom signal score.
Global footprint
Where Kymera Therapeutics has talent and traffic
team presence
across markets
Talent graph
The shape of Kymera Therapeutics's talent
Dealroom maps Kymera Therapeutics's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$28M patent portfolio · 98 active families
Where Kymera Therapeutics concentrates vs peers
Each axis is a top-10 topic across Kymera Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Kymera Therapeutics
An AI-synthesized read of the highest-engagement posts about Kymera Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Kymera Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.